台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-兆豐-板橋 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

兆豐-板橋 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/02161.4000.0061.8014700.21%
2025/04/22557.5000.0055.5054711.06%
2025/04/212458.6000.0058.00244755.04%
2025/04/171158.9400.0058.60114892.25%
2025/04/15260.5000.0060.1024900.41%
2025/04/111759.8700.0059.20174933.44%
2025/03/3100.00168.5067.50-1561-0.18%
2025/03/25174.6000.0076.0015940.17%
2025/03/14277.5000.0077.7026170.32%
2025/03/1300.00179.4081.00-1603-0.17%
2025/03/12178.10779.9077.50-6585-1.02%
2025/03/11878.6900.0081.5085571.43%
2025/03/0400.00169.5069.60-1483-0.21%
2025/02/2000.00165.0071.00-1497-0.20%
2025/02/1200.006.163.2561.90-6.1585-1.04%
2025/02/06660.9300.0060.6066001.00%
2025/02/05160.9000.0060.7016050.17%
2025/02/04261.5000.0060.7026050.33%
2024/12/1100.00355.0054.90-3666-0.45%
2024/12/05165.9000.0065.5016550.15%
2024/12/03367.5000.0067.8036620.45%
2024/11/1500.00269.0066.00-2678-0.29%
2024/10/0700.0050113.09116.50-50830-6.02%
2024/10/045091.00191.00106.50498136.03%
2024/09/261140.0000.00133.0017850.13%
2024/09/2400.002169.50159.00-2789-0.25%
2024/09/232152.5000.00158.0027940.25%
2024/08/276223.0000.00220.0067850.76%
2024/08/231217.0000.00229.0017980.13%
2024/08/2212222.5000.00221.50127981.50%
2024/08/1910193.5010198.00201.5008200.00%
2024/08/1600.0010199.25200.50-10822-1.22%
2024/08/145187.908192.81192.00-3841-0.36%
2024/08/135189.805194.50189.0008430.00%
2024/08/1215198.6700.00198.00158351.80%
2024/08/0900.0020203.45203.50-20824-2.43%
2024/08/0810185.0010188.00187.0007940.00%
2024/08/0100.005173.40175.50-5732-0.68%
2024/07/225164.0000.00164.0056670.75%
2024/07/193183.5000.00182.0036500.46%
2024/07/1000.001152.50152.50-1512-0.19%
2024/07/033126.0000.00124.5034740.63%
2024/07/023136.0000.00138.0034460.67%
2024/07/0110136.2500.00137.50104352.30%
2024/06/2800.008121.00130.00-8413-1.93%
2024/05/29098.6000.0094.5003190.00%
2024/05/27098.5000.00100.0003070.00%
2024/05/2000.00185.9086.30-1238-0.42%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音